Rejuvenation Technologies Inc.
Rejuvenation Technologies Inc., based in Mountain View, CA, is a healthcare company focusing on extending human health span by developing TERT mRNA-based therapies that reverse telomere shortening, a key factor in aging.
Company Overview
Rejuvenation Technologies Inc., located in Mountain View, CA, focuses on extending the human health span through cutting-edge therapeutics. Specializing in TERT mRNA-based therapies, the company aims to reverse over a decade of telomere shortening within a matter of days. It operates in the healthcare industry, specifically within therapeutics, and is a part of the Y Combinator S18 batch. With a small team size of two, Rejuvenation Technologies is at an early stage of its development.
Technologies and Therapeutic Approaches
Rejuvenation Technologies develops highly efficient telomere extension and synergistic regenerative therapeutics. The central technology involves telomerase mRNA encapsulated in nanoparticles to facilitate cellular uptake. One dose of this therapy can reverse years of telomere shortening in mere hours. The company's innovative approaches were invented by its founders at Stanford University, marking significant advancement in the field of gene therapy and nanomedicine.
Research and Development Pipeline
Rejuvenation Technologies has a comprehensive pipeline that includes a targeted lung program. This program is moving through detailed stages of development, reflecting the company's commitment to advancing telomere-extension therapies to the clinic. The R&D efforts are aligned with their mission to combat aging by focusing on reversing telomere shortening, a key factor associated with the aging process.
Locations and Services
Headquartered in Mountain View, CA, Rejuvenation Technologies operates primarily within the United States and Canada. The company supports a range of service models including remote and partly remote configurations. This flexibility ensures engagement with a wider demographic, accommodating various needs for both employment and service offerings.
Y Combinator and Market Presence
Rejuvenation Technologies was part of the Y Combinator S18 batch, a significant milestone that highlights its credibility and potential for growth. The company's market presence spans across the United States and Canada, emphasizing its focus on pioneering anti-aging and gene therapy solutions. Tags associated with the company include Anti-Aging, Gene Therapy, and Nanomedicine, indicating its specialized focus within the therapeutics sub-industry.